➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

CREON Drug Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: CREON

Patents:	42
Applicants:	2
BLAs:	1
Suppliers: see list	1
Drug Prices:	Drug price information for CREON

Drug Prices for CREON

See drug prices for CREON

Patent Text Search: US Patents for CREON

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Abbvie	CREON	pancrelipase (amylase;lipase;protease)	CAPSULE, DELAYED RELEASE;ORAL	020725	001	2009-04-30	Start Trial	ASCENDIS PHARMA A/S (Hellrup, DK)	2024-07-05	RX		search
Abbvie	CREON	pancrelipase (amylase;lipase;protease)	CAPSULE, DELAYED RELEASE;ORAL	020725	001	2009-04-30	Start Trial	Emory University (Atlanta, GA)	2031-06-20	RX		search
Abbvie	CREON	pancrelipase (amylase;lipase;protease)	CAPSULE, DELAYED RELEASE;ORAL	020725	001	2009-04-30	Start Trial	APTALIS PHARMA CANADA ULC (CA)	2040-03-30	RX		search
Abbvie	CREON	pancrelipase (amylase;lipase;protease)	CAPSULE, DELAYED RELEASE;ORAL	020725	001	2009-04-30	Start Trial	ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (Dublin, IE)	2034-06-19	RX		search
Abbvie	CREON	pancrelipase (amylase;lipase;protease)	CAPSULE, DELAYED RELEASE;ORAL	020725	001	2009-04-30	Start Trial	ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (Dublin, IE)	2027-02-20	RX		search
Abbvie	CREON	pancrelipase (amylase;lipase;protease)	CAPSULE, DELAYED RELEASE;ORAL	020725	001	2009-04-30	Start Trial	Horizon Orphan LLC (Lake Forest, IL)	2029-09-04	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for CREON

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Canada	2513893	Start Trial
Australia	2014264936	Start Trial
New Zealand	598477	Start Trial
European Patent Office	2594291	Start Trial
Japan	2019112449	Start Trial
Israel	200407	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

Dow

Merck

Colorcon

Mallinckrodt

Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.